Mosby's Dental Drug Reference 2005

Mosby''s Dental Drug Reference 2005 is an up-to-date drug resource designed to be used chair side in the dental office. The user-friendly design provides easy access to essential information on over 1,600 of the most commonly prescribed drug products, including the top 200 prescription drugs in the United States. An easy-to-use cross index is the key to using this book for both brand and generic name identification. A second index, based on a therapeutic and pharmacologic...
More Description

Mosby''s Dental Drug Reference 2005 is an up-to-date drug resource designed to be used chair side in the dental office. The user-friendly design provides easy access to essential information on over 1,600 of the most commonly prescribed drug products, including the top 200 prescription drugs in the United States. An easy-to-use cross index is the key to using this book for both brand and generic name identification. A second index, based on a therapeutic and pharmacologic classification, can also be used to quickly locate drug monographs. The 2005 edition contains a 20-page insert at the back of the book, entitled New Drug Updates, with information on new drugs that have recently received FDA approval. This reference book easily fits in the pocket of a clinic coat and the soft cover design reduces bulk and weight, making it ideal for use in any dental office.

• CD-ROM bound in the back of each book contains 30 full-color images of pathologic conditions that may result from drugs patients are taking. Each drug is cross-referenced to the page in the book where the drug is discussed. The CD also contains over 950 patient education sheets (customizable to include specific practice information). These sheets provide patients with invaluable drug information and specific instructions, and all are available in both English and Spanish.
• Dental alert icons highlight oral side effects
• Drug interaction icons designate interactions of concern to dentistry
• Provides information on the top 200 prescription drugs in the United States
• Complete and consistent monographs of more than 1,600 commonly used drug products
• 11 useful appendixes
• Therapeutic/pharmacologic index
• The Dental Considerations section includes dental treatment warnings related to medical indications for each drug. It also offers treatment plan modifications related to drug side effects.
• For each drug profiled, you will find:
• Generic name of the drug (includes pronunciation)
• Common brand names (includes Canadian availability, which is indicated by a maple leaf)
• Drug class, to facilitate drug identification
• Controlled substances schedule as appropriate for the U.S. and Canada
  
• A brief description of the mechanism of action of the drug
• Uses for the drug, including those approved by the FDA (unapproved uses are identified as appropriate for selected drugs)
• Administration (Including doses and routes, to assist in assessing seriousness of the patient''s disease and for predicting potential side effects and drug interactions)
  
• Side effects/adverse reactions grouped according to body systems (Common side effects are listed in italics; life-threatening reactions are in boldface, italic type. Information regarding oral manifestations of side effects is listed separately.
• Contraindications in which the medication should absolutely not be given or when risk/benefit criteria must be established
• Precautions to be considered when prescribing and using the drug, along with identification of pregnancy categories
• Pharmacokinetics (briefly described for each drug)
• Drug interactions of concern to dentistry, helping you exercise clinical judgment regarding both beneficial and harmful interactions
• Dental considerations, including general information, suggestions for medical consultations, and recommendations for the patient/family in preventing dental complications

• 53 new drugs that have recently received FDA approval.
• 56 new combination drug products.
• 11 new drugs not likely to be encountered in the dental office.
• Five new patient education sheets to the accompanying CD, including the drugs: Vicodin, Anaprox, Valium, Tylenol with Codeine, and Darvocet.
• New 20-page insert, entitled New Drug Updates, with information on new drugs that have recently received FDA approval